Back to User profile » Dr Yanling Feng

Papers published by Dr Yanling Feng:


Adverse Event Management in Patients with Platinum-Resistant Ovarian Cancer Treated with Niraparib and Anlotinib: Updates from the Phase II, Multi-Center ANNIE Study

Deng T, Yan L, Li J, Liu G, Yin A, Feng Y, Zheng M, Zhang C, Huang H, Huang Q, Lin A, Jiang J, Kong B, Liu J

Therapeutics and Clinical Risk Management 2025, 21:1135-1147

Published Date: 21 July 2025

Tumor-induced VEGF-C overexpression in retroperitoneal lymph nodes in VX2 carcinoma-bearing rabbits

Huang YW, Zhou Y, Lan CY, Wang Y, Feng YL, Luo RZ, Liu JH

Drug Design, Development and Therapy 2015, 9:5949-5956

Published Date: 5 November 2015